GeneDx Holdings Corp. (WGS)
- Previous Close
109.39 - Open
109.19 - Bid 80.39 x 200
- Ask 138.99 x 200
- Day's Range
107.96 - 112.00 - 52 Week Range
10.70 - 115.60 - Volume
614,274 - Avg. Volume
1,016,726 - Market Cap (intraday)
3.167B - Beta (5Y Monthly) 2.00
- PE Ratio (TTM)
-- - EPS (TTM)
-1.94 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
107.83
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
www.genedx.com1,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WGS
View MorePerformance Overview: WGS
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WGS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WGS
View MoreValuation Measures
Market Cap
3.12B
Enterprise Value
3.10B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.63
Price/Book (mrq)
12.73
Enterprise Value/Revenue
10.14
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-17.12%
Return on Assets (ttm)
-3.20%
Return on Equity (ttm)
-22.10%
Revenue (ttm)
305.45M
Net Income Avi to Common (ttm)
-52.29M
Diluted EPS (ttm)
-1.94
Balance Sheet and Cash Flow
Total Cash (mrq)
141.18M
Total Debt/Equity (mrq)
47.37%
Levered Free Cash Flow (ttm)
1.11M